The biotechnology giant Amgen is expected to plead guilty Tuesday to illegally marketing its drugs, people close to the investigation said Monday.
Amgen expected to plead guilty in U.S. case
Send us a letter
Have an opinion about this story? Click here to submit a Letter to the Editor, and we may publish it in print.